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Toxoplasmagondii is anobligate, intracellular eukaryotic api-
complexan protozoan parasite that can cause fetal damage and
abortion in both animals and humans. Sphingolipids are essen-
tial and ubiquitous components of eukaryotic membranes that
are both synthesized and scavenged by the Apicomplexa. Here
we report the identification, isolation, and analyses of the Tox-
oplasma serine palmitoyltransferase, an enzyme catalyzing the
first and rate-limiting step in sphingolipidbiosynthesis: the con-
densation of serine and palmitoyl-CoA. In all eukaryotes ana-
lyzed to date, serine palmitoyltransferase is a highly conserved
heterodimeric enzyme complex. However, biochemical and
structural analyses demonstrated the apicomplexan orthologue
to be a functional, homodimeric serine palmitoyltransferase
localized to the endoplasmic reticulum. Furthermore, phyloge-
netic studies indicated that it was evolutionarily related to the
prokaryotic serine palmitoyltransferase, identified in the Sphin-
gomonadaceae as a soluble homodimeric enzyme. Therefore
this enzyme, conserved throughout theApicomplexa, is likely to
have been obtained via lateral gene transfer from a prokaryote.
Toxoplasma gondii is an obligate, intracellular protozoan
parasite that is able to invade and colonize a wide variety of
nucleated vertebrate cells. It is a member of the Apicomplexa, a
diverse phylum including important pathogens of humans and
domestic animals such as Plasmodium (the causative agent of
malaria), Cryptosporidium (diarrhea), Eimeria (coccidiosis in
poultry), and Theileria (East Coast fever in cattle). Toxoplasma
has emerged as an important opportunistic pathogen, and
toxoplasmosis is one of the primary opportunistic diseases in
the immunocompromised, particularly AIDS patients, those
receiving anti-cancer chemotherapy, and organ transplant
recipients (1).Toxoplasma infection in utero is also a significant
cause of spontaneous abortion in economically important
domestic animals (2) and congenital defects in humans (1).
As an intracellular parasite, Toxoplasma has a dynamic rela-
tionship with its host cell, including both the synthesis and
scavenging of key lipid species (3, 4), such as sphingolipids
(5–7). Sphingolipids are amphipathic lipids consisting of a sph-
ingoid backbone acylated with a long-chain fatty acid and hav-
ing a polar head group. Although the basic sphingolipid, cer-
amide, is a secondary signaling molecule involved in, for
example, apoptosis (8–10), modified or complex sphingolipids
are major components of the outer leaflet of eukaryotic plasma
membranes involved, together with sterols, in the formation of
microdomains commonly known as lipid rafts. These domains
have been proposed to function in a diverse array of processes
from the polarized trafficking of lipid-modified proteins to the
assembly and activation of signal transduction complexes (11).
The first, rate-limiting enzyme in sphingolipid biosynthesis is
serine palmitoyltransferase (SPT),2 a pyridoxal phosphate
(PLP)-dependent class II aminotransferase that catalyzes the
Claisen-like condensation of L-serine and, typically, palmitoyl-
CoA to form 3-ketodihydrosphingosine (KDS) (12) (Fig. 1).
Subsequently, N-acylation of the sphingoid base in the endo-
plasmic reticulum (ER) leads to the formation of ceramide. Fol-
lowing transport to the Golgi apparatus, ceramide is used to
form modified or complex sphingolipids, sphingomyelin (SM),
or glycosphingolipid (GSL), for example (10, 13). In all
eukaryotes studied to date, SPT is composed of a core het-
erodimer of two evolutionary related proteins that spans the
membrane of the ER (14). One subunit, LCB2, contains
the canonical PLP-binding and catalysis domain, whereas the
other, LCB1, is not thought to bind this co-factor but to be
important for complex stability (12). Both subunits are essential
for enzyme activity in Saccharomyces cerevisiae (15), and anal-
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that de novo synthesis of sphingolipids and their precursors is
pivotal in a wide spectrum of cellular processes including endo-
cytosis, stress responses, and protein trafficking (16–18).
Members of the Prokaryota also encode a functional SPT,
which was first characterized in Sphingomonas paucimobilis
(12, 19). However, in contrast to the eukaryotic paralogue, the
bacterial enzyme is a soluble, homodimeric PLP-dependent
class II aminotransferase andhas beenproposed to represent an
evolutionary precursor of the heterodimeric eukaryotic SPT
(20). Despite the divergence in primary sequence, the crystal
structure of the S. paucimobilis enzyme revealed a symmetrical
dimer with the co-factor PLP bound to each subunit in a man-
ner predicted to be conserved in the eukaryotic SPT subunit,
LCB2 (21).
Like other eukaryotes, apicomplexan Toxoplasma and Plas-
modium spp. synthesize sphingolipids de novo, including both
SM and GSLs (5, 22, 23). Sphingolipid-enriched lipid microdo-
mains have been implicated in the interaction of Plasmodium
falciparum with the host erythrocyte (24). However, host sph-
ingolipid biosynthesis is non-essential for the proliferation of
Toxoplasma (6, 7), indicating that de novo synthesis is impor-
tant for parasitism (3). Toxoplasma were known to produce
both SM and GSLs (5), but until recently the mechanics of sph-
ingolipid metabolism in Toxoplasma and other apicomplexans
remained enigmatic. However, the first functionally character-
ized enzyme in the apicomplexan sphingolipid biosynthetic
pathway has now been described as an ortholog of the yeast
inositol phosphorylceramide synthase (an enzyme with no
mammalian equivalent) (6). To enable further understanding
and analyses, the identification and characterization of the key
enzyme components in the apicomplexan de novo pathway is
essential. Although our characterization of the Toxoplasma
inositol phosphorylceramide synthase has initiated this process
(6) significant gaps remain, not least the formal identification of
the apicomplexan SPT, the first and rate-limiting step in sph-
ingolipid biosynthesis (12). Importantly, in the absence of a
defined SPT, the incorporation of tritiated serine into sphingo-
lipid species during metabolic labeling of isolated Toxoplasma
and P. falciparum indicated the presence of an active apicom-
pexan SPT (22, 25).
Here we describe the identification and characterization of
the Toxoplasma SPT, which represents a new class of eukary-
otic enzyme with a very surprising, prokaryotic, origin. These
studies shed new light on the evolution of these protozoan par-
asites and present a paradigm shift in the way the origin of
sphingolipid biosynthesis is considered.
Results
A putative apicomplexan serine palmitoyltransferase
In all eukaryotes studied to date, including members of the
protozoa, the first enzyme in the sphingolipid biosynthetic
pathway, SPT (13), is composed of two related subunits (LCB1
and LCB2) (26). However, initial BLAST searches of the com-
plete, annotated genome databases of both T. gondii (http://
toxodb.org (60)) andP. falciparum (http://plasmodb.org (61)),3
using a range of LCB1 and LCB2 protein sequences, failed to
locate genes encoding either SPT subunit. Given that both of
these parasites have been shown to possess SPT activity (22,
25), this represented a major paradox.
Further interrogation of the Toxoplasma genome database
using BLAST and the conserved 10 residue PLP-binding
domain (PROSITE consensus PS00599) common to all eukary-
otic SPT LCB2 proteins (27), identified two closely related (68%
identical), tandemly encoded, predicted type II PLP-dependent
aminotransferases with no known function. Surprisingly, the
putative PLP-binding sites from both proteins were both com-
pletely conserved with respect to the 12 residue PLP-binding
motif (GTFSKSXXXXGG) identified in the Sphingomon-
adaceae bacterial SPT (28). Further analyses demonstrated that
the best characterized bacterial SPT, from S. paucimobilis,
showed limited homology with the identified Toxoplasma pro-
teins: 28 and 30% identity and 47 and 46% similarity in the
C-terminal region (64% of total predicted protein) of TgSPT1
and TgSPT2, respectively (20). In addition, using the BLAST
tool and the predicted Toxoplasma protein sequences, singly
encoded orthologues of the putative apicomplexan SPT were
also found in the genomedatabases ofPlasmodium spp. and the
chicken pathogen Eimeria tenella. Comparison of the primary
amino acid sequences of the putative apicomplexan proteins
with the bacterial SPT indicated the presence of anN-terminal
extension,whichharbors a transmembrane region absent in the
prokaryotic polypeptide (Fig. 2).
Taken together, these observations clearly indicated that the
putative apicomplexan SPT is radically different to those of all
other eukaryotes studied thus far. To prove this, it was vital to
demonstrate the functionality of the apicomplexan SPT.
TgSPT1 is a functional serine palmitoyltransferase
The complete open reading frame of the predominant,
tachyzoite expressed, Toxoplasma SPT, TgSPT1 (see http://
toxodb.org for transcriptomic data),3 was cloned into the yeast
expression vector, pRS426-MET, to create pRS426-TgSPT1. In
the auxotrophic yeast strain YPH499-HIS-GAL-LCB2, the
essential PLP-binding, catalytic SPT subunit LCB2 (15) is under
the control of a GAL1 promoter. In non-permissive glucose-
containing SD medium, which inhibits expression from the
GAL1 promoter, the yeast are non-viable. Transformationwith
pRS426-TgSPT1 allowed the growth of YPH499-HIS-GAL-
3 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Figure 1. Schematic showing the chemical reaction catalyzed by the SPT
inwhich theenzymecatalyzes thecondensationof serineandpalmitoyl-
CoA to form KDSwith the release of coenzyme A (HSCoA) and CO2.
The apicomplexan serine palmitoyltransferase
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LCB2 in thismedia, as did the ectopic expression of S. cerevisiae
LCB2. In contrast, the empty vector, pRS426-MET, did not res-
cue the growth of the auxotrophic yeast strain (Fig. 3). These
data strongly indicate that TgSPT1 is a functional orthologue of
the S. cerevisiae LCB2 and, therefore, at least part of the T. gon-
dii serine palmitoyltransferase.
To analyze the functionality of TgSPT1 in vitro, a series of
constructs were made in collaboration with the Oxford Protein
Purification Facility in the vector pOPINS3C, where the insert
is N-terminally fused to a cleavable N-HIS SUMO tag (29, 30).
Following triage based on expression levels and product solu-
bility, a series of these fusion proteins (with N-terminal dele-
tions of 143, 158, 176, and 180 amino acids) were expressed,
purified, and subjected to preliminary functional analyses using
palmitoyl-CoA and 14C-labeled serine as substrates (supple-
mental Fig. S1). The truncated construct TgSPT1 158 was
selected for further analyses. Mass spectrometry demonstrated
the reaction product of the enzyme to be KDS (Fig. 4), and
therefore TgSPT1 is a bona fide SPT.
To further understand enzyme function, small-angle X-ray
scattering (SAXS) was utilized to determine the shape of the
protein in solution and investigate whether TgSPT1 forms a
homodimer similar to the bacterial orthologue. The results
are summarized in Fig. 5A, which shows the experimentally
derived shape of the molecule in gray as a bead model and
superimposed a ribbon diagram of the homodimeric homology
model of TgSPT1 based on the known crystal structure of the
Sphingobacterium multivorum SPT (52). The ab initio enve-
lope shows very good agreement with the homodimeric model,
where the core of the enzyme adopts a similar conformation to
the bacterial orthologue. The elongated shape of the envelope
indicated increased conformational flexibility of the termini of
the protein. Using the homology model of the TgSPT1 dimer,
the theoretical X-ray scattering data calculated with CRYSOL
(31) revealed some discrepancies with the experimental data
(Fig. 5B). Although the shape of the curve was similar, the low
intensity values are higher in the experimental data consistent
with a more elongated/or larger shape as shown in the ab initio
envelope. Furthermore, the homologymodel indicated that the
co-factor PLP can bind precisely to the predicted binding
motifs in eachmonomer at the dimer interface of the structural
model (Fig. 5C). Therefore, the Toxoplasma and by extension
the apicomplexan SPTs are functional as homodimers. This
resembles the bacterial situation (19) rather than the so far uni-
versal eukaryotic model of core heterodimeric modality (14).
However, in contrast to the Prokaryota, where SPT is a soluble
enzyme (20), the eukaryotic enzyme complex is associated with
themembrane of the endoplasmic reticulum (14). As discussed
above, the N-terminal extension contains a predicted trans-
membrane domain, and the data indicate that this does not
influence functionality in vitro. It is noteworthy that Uniprot
(www.uniprot.org) has predicted the P. falciparum SPT N-ter-
minal region to target the protein to the apicoplast (32), a ves-
tigial plastid that harbors the machinery for several lipid bio-
synthetic pathways (33). However, the ability of TgSPT1 to
complement for a deficiency of LCB2 in auxotrophic mutant
yeast (Fig. 3) indicated that the protozoal enzyme is targeted to
the ER, which is the locale for SPT activity in this and other
eukaryotes (14). Episomal expression of tagged TgSPT1-TY
and the ERmarker GFP-HDEL (34, 35) allowed co-localization
by immunofluorescence microscopy and indicated that
TgSPT1 is an ER rather than apicoplast-localized enzyme in
Toxoplasma (Fig. 6, A–D). Furthermore, using a rat polyclonal
antibody raised against TgSPT1 158, the native protein was
shown to have a similar ER localization pattern (Fig. 6, E–H).
Looking at a larger vacuole showed the same localization pat-
tern of native TgSPT1 (Fig. 7, A–D). In addition, the larger
quantity of data available here facilitated quantitative co-local-
ization analyses illustrated by scatterplots (Fig. 7, E–G). These
show two-dimensional histograms of differentially labeled cell
compartments (see axes labels for the channel/wavelength) at
the same spatial region. A linear correlation demonstrates a
strong spatial correlation between the channels, and the slope
indicates the relative intensities (36, 37). The plot in Fig. 7E
demonstrated a strong correlation of TgSPT1 (antiSPT-AF594)
with GFP-HDEL (antiGFP-AF488) and ER localization. In con-
trast, neither TgSPT1 (antiSPT-AF594) nor GFP-HDEL (anti-
GFP-AF488) showed any significant correlation with DAPI-
stained nuclei (Fig. 7, F and G). In an additional control
experiment, TgSPT1 (antiSPT-AF594) showed no significant
correlation with episomally expressed, cytosolic GFP (supple-
mental Fig. S2). Together, these data demonstrated that
TgSPT1 has a canonical eukaryotic subcellular localization,
the ER.
In summary, TgSPT1 represents a new class of eukaryotic
SPTs found in the Apicomplexa. Although it functionally and
structurally resembles the prokaryotic enzymes, its membrane
localization and place in an apparently conventional eukaryotic
synthetic pathway (6) demonstrate that it serves a conventional
eukaryotic role.
Figure 2. Sequence alignment of the predicted SPT from fourmembers of theApicomplexa (T. gondii, TgSPT1 and TgSPT2; E. tenella, EtSPT; P. falcip-
arum, PfSPT; and Plasmodiumvivax, PvSPT) and the characterized enzyme from the prokaryote S. paucimobilis (SpSPT).Conserved residues (including
those in the active site) identified by analyses of the SpSPT structure and homology modeling of the human functional orthologue (LCB2), are highlighted in
red, with red text denoting similarity. Blue boxes denote conserved domains. The canonical lysine demonstrated to form an internal aldiminewith the co-factor
PLP at SpSPT position 265 is highlighted (21). The N-terminal extensions unique to the predicted apicomplexan enzymes harbor a transmembrane domain
predicted by TMPRED (TMD, bold and underlined). The figure was produced using ESPript 3.0 (59).
Figure 3. Transformed auxotrophic yeast grown on selective medium
witheithergalactose (A) orglucose (B).Both ScLcb2andTgSPT1 rescue the
mutant S. cerevisiae that are deficient in endogenous ScLcb2 when grown in
the presence of glucose (B). pRS246 is the empty vector control.
The apicomplexan serine palmitoyltransferase
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A surprising evolutionary origin for the apicomplexan serine
palmitoyltransferase
The data presented above detail the identification and func-
tional characterization of TgSPT1, a eukaryotic enzyme, which
in terms of its primary sequence and homodimeric structure
resembles the prokaryotic “sister” enzymes. Our comprehen-
sive sequence searches of the protozoan genome databases
identified closely related orthologues of TgSPT1/2 in Plasmo-
dium spp., E. tenella, and Cryptosporidium muris. Unlike Tox-
oplasma, these members of the Apicomplexa maintain a single
SPT copy, indicating that TgSPT1 and TgSPT2 resulted from a
gene duplication event that occurred post-speciation of the
phylum. Interestingly, Cryptosporidium hominis and Crypto-
sporidium parvum, unlike C. muris, completely lack any gene
encoding for SPT, despite the genomic region being syntenic
between all three species (Fig. 8A). This suggests that C. homi-
nis and C. parvum have selectively lost the first and rate-limit-
ing step in sphingolipid biosynthesis, probably reflecting a spe-
cific adaptation of the parasite-host relationship.
To further analyze the evolutionary origin of the divergent
apicomplexan SPT, phylogenetic analyses of a conserved
region, including the PLP-binding site, were carried out. Using
ClustalW (38) to align the predominant conserved region (Fig.
2 and supplemental Fig. S3), followed by Fitch Margoliash dis-
tance (F-MDist) (39), randomized acceleratedmaximum likeli-
hood (RAxML) (40), and phylogeny maximum likelihood
(PhyML) (41), the relationship of the apicomplexan SPT with
both the eukaryotic catalytic subunit, LCB2, and the prokary-
otic homodimeric SPT were determined (Fig. 8B). It was clear
that the apicomplexan sequences do not represent conven-
tional eukaryotic LCB2, with the kingdom to which they
belong, the Chromalveolatea, split across the twomajor clades.
The predicted catalytic subunits of the SPT from the Chromal-
veolate Thalassiosira pseudonana and Phytophthora ramorum
groupwith high certaintywith the conventional LCB2 subunits;
however, the apicomplexan SPTs form a clade, supported by
bootstrap values, with the prokaryotic sequences. This bioin-
formatic approach strongly indicated that the homodimeric
apicomplexan enzyme is a divergent eukaryotic SPT of pro-
karyotic origin.
Discussion
The Toxoplasma serine palmitoyltransferase, TgSPT, was
identified as being encoded by two closely related genes andwas
found to be conserved as a single copy throughout the Apicom-
plexa.TgSPT1demonstratedtheabilitytocomplementanauxo-
trophic yeast LCB2mutant, and functionality was confirmed by
analyses of expressed and purified TgSPT1. However, the pre-
dicted protozoan enzyme is highly divergent compared with
the heterodimeric enzyme characterized throughout the
Eukaryota. SAXS, coupled with homology modeling, demon-
strated that the protein forms a homodimer, thereby resem-
bling the prokaryotic rather that the eukaryotic paralogue. This
relationship was further confirmed by phylogenetic analyses,
which demonstrated the apicomplexan sequences as being
most closely related to the prokaryotic SPT, with the protozoan
SPT showing divergence from the catalytic SPT subunit (LCB2)
in all other eukaryotes, including fellow members of the Chro-
malveolata. These data strongly indicated that the apicompl-
exan SPT was derived from horizontal transfer from a prokary-
otic species (probably a member of Alphaproteobacteria) and
demonstrated that the evolution of eukaryotic sphingolipid
biosynthesis is more complex than previously recognized.
These data also add to the evolutionary complexity of the Api-
complexa, protozoan parasites known to harbor a vestigial plas-
tid (the apicoplast) as a remnant of an ancient algal endosym-
biotic event (42).
Experimental procedures
Bioinformatics analyses
The 10 residue canonical, degenerate, PLP-binding domain
common to all eukaryotic SPT subunit 2 proteins (43) was
used to search the complete genome database of T. gondii
(http://toxodb.org)3 with WU-BLAST (Gish, W. (1996–2003)).
Two hits were identified: TGME49_090980 (TgSPT1) and
TGME49_090970 (TgSPT2). The protein sequence of TgSPT1
and WU-BLAST were subsequently used to search the Plas-
modium, Eimeria, and Cryptosporidium genome databases
(http://plasmodb.org and http://genedb.org).3 NCBI-BLAST
was used to compare the hits against the NCBI protein
Figure 4. Mass spectrometry positive ion spectrum of lipids extracted from in vitro reaction of TgSPT1 158 with serine and palmitoyl CoA as
substrates. The peak 300.29 corresponds to the mass of 3-ketodihydrosphinganine.
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sequence database. Exploiting the structural data available for
the bacterial S. paucimobilis enzyme (21), representatives of
the apicomplexan andbacterial SPTswere alignedusingT-Cof-
fee Expresso (44). The resulting multiple sequence alignment
was reformatted in T-Coffee with the command “t_coffee -oth-
er_pg seq_reformat -inmsa -output sim” to yield the iden-
tity values.
TgSPT1 isolation and cloning
T.gondiiRHhxgprt- were propagated in vero cells (both kind
gifts from Dominique Soldati-Favre, University of Geneva,
Geneva, Switzerland) and isolated as described previously (45).
RNA was then extracted using the RNeasy kit (Qiagen)
according to the yeast protocol. Following quantitation using
Nanodrop 2000 (ThermoFisher), cDNA was synthesized
using random primers and the SuperScript III kit (Thermo-
Figure 5. A, SAXS generated envelope overlaying a homology model of the
TgSPT1 dimer. B, SAXS data (binned mode as blue dots), superimposed with
the calculated scattering curve using the homologymode (in red).C, close-up
of the PLPbinding site of the homologymodel of TgSPT1basedon the crystal
structure of SPT from S. multivorum. The key PLP binding residues depicted
with cyanbonds in a ball-and-stick representation are conserved in the family
(see Fig. 2). The numbering corresponds to the TgSPT1 sequence. Note that
Ser-429/B belongs to the second subunit of the homodimer.
Figure 6. Toxoplasma stained for ectopically expressed TgSPT1-TY (A,
AlexaFluor594, red) and endogenous TgSPT1 (E, AlexaFluor594, red);
ectopically expressed ER marker GFP-HDEL (B and F, AlexaFluor488,
green); and DNA (C and G, DAPI, blue). Co-localization of TgSPT1, ectopi-
cally expressed and endogenous, with GFP-HDEL is shown inmerge of A and
B (D, yellow) and E and F (H, yellow), respectively. The scale bar is equivalent to
10 m.
The apicomplexan serine palmitoyltransferase
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Fisher) as directed by the manufacturer. Full-length TgSPT1
was then amplified by PCR using the proofreading DNA poly-
merase Pfu (Promega) and primers TgSPT5HindIII CCC-
AAGCTTGCATGGCTTCGGGTGCAACGTACTTC and
TgSPT3NotI ATAAGAATGCGGCCGCTCATCGGAG-
CATGTCAGTGGGTGGG (restriction sites in bold). The cod-
ing sequence was then cloned into the pET24a vector (Nova-
gen). Subsequently, a series of deletion constructs were cloned
into a series of pOPIN bacterial expression and, following
transformation in a variety of Escherichia coli strains, screened
for expression of soluble protein at the Oxford Protein Produc-
tion Facility using their standardized protocols for high
throughput analyses (30).
Yeast complementation
The YPH499-HIS-GAL-LCB2 S. cerevisiae strain was con-
structed in YPH499 (Mat a; ura3-52; lys2-801amber; ade2-
101ochre; trp1-63; his3-200; leu2-1) (Stratagene) by bringing
the expression of the yeast LCB2 gene under the control of the
stringently regulated GAL1 promoter that is repressed in the
presence of glucose as described before (25, 46). The following
primer sequences were used for amplification of the HIS/GAL
Figure 7. Endogenous TgSPT1 (A, AlexaFluor594, red) andectopically expressedERmarkerGFP-HDEL (B, AlexaFluor488,green) co-localize as shown
in the merged image (D, yellow). The scale bar is equivalent to 10 m. In support of this, the scatterplot (E) demonstrates the strong correlation of TgSPT1
(antiSPT-AF594) with GFP-HDEL (antiGFP-AF488). In contrast, neither TgSPT1 (antiSPT-AF594) nor GFP-HDEL (antiGFP-AF488) show any significant correlation
with DAPI-stained (C) nuclei (F and G). The color scale represents the number of pixels as indicated.
The apicomplexan serine palmitoyltransferase
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cassette: (a) sequence for integration upstream of the coding
region (nucleotides 200 to 150) Lcb2HisGalS, TAAGT-
TTCATTACTATTTTCTATTATTATCTGCAACTTTT-
TATTAGTTAGgggcgaattggagctccac and (b) sequence for
integration at the initiation codon (nucleotides 1 to 50
Lcb2HisGalAS, TAAGTTTCATTACTATTTTCTATTAT-
TATCTGCAACTTTTTATTAGTTAGgggcgaattggagctccac.
The numbers indicate the nucleotide positions in the S. cerevi-
siae DNA sequence, with the adenosine of the ATG initiation
codonbeing defined as position1. The 19-bp sequences at the
3 ends of these oligonucleotides that are homologous to the
sequences of the vector pGAL/HIS3 and serve as a template for
amplification of the GAL1/HIS3-cassette are shown with low-
ercase letters. Transformation into the haploid YPH499 strain,
selection on minimal medium lacking histidine but containing
galactose, and confirmation of the insertion of the HIS-GAL
fragment were performed as previously (46). YPH499-HIS-
GAL-LCB2 was maintained in SGR medium (4% galactose, 2%
raffinose, 0.17% Bacto yeast nitrogen base, 0.5% ammonium
sulfate) with galactose/raffinose rather than non-permissive
dextrose as the carbohydrate source. For rapid cultivation of
the mutant, YPGR medium (4% galactose, 2% raffinose, 1%
yeast extract, 2% peptone) was routinely used.
The S. cerevisiae lcb2 coding region was amplified from
genomic DNA (Invitrogen) using primers (Sclcb2SEcoRI GGG-
GAATTCATGAGTACTCCTGCAAACTATACCCG and
Sclcb2ASXhoI GGGCTCGAGAACAAAATACTTGTCGTC-
CTTACAATC, with restriction sites shown in bold type), and
the product was cloned into pRS426MET25 to create pRS426
ScLCB2. Similarly, the TgSPT1 coding sequence was amplified
(TgSPT5SpeI ACTAGTATGGCTTCGGGTGCAACG-
TACTTC and TgSPT3HindIII CGCAAGCTTTCATCG-
GAGCATGTCAGTGGGTGG, with restriction sites in bold
type) and cloned into the yeast expression vector to create
pRS246 TgSPT1. The YPH499-HIS-GAL-LCB2 S. cerevisiae
strain was transformed with pRS426 ScLCB2 or pRS426
TgSPT1 and functionally complemented transformants se-
lected on non-permissive SD medium (0.17% Bacto yeast
nitrogen base, 0.5% ammonium sulfate, and 2% dextrose) con-
taining the nutritional supplements necessary to allow selec-
tion of transformants.
TgSPT1 protein production and purification
At the Oxford Protein Purification Facility four N-terminal
deletion constructs (TgSPT1 143, 158, 177, and 180) in
the pOPINS3C vector (containing a HIS-SUMO tag and a 3C
protease cleavage site) showed good expression levels of soluble
protein in Rosetta II (DE3) pLysS E. coli grown in Overnight
ExpressTM Instant TB autoinduction medium (Novagen) with
50 g/ml ampicillin and 35 g/ml chloramphenicol (Sigma-
Aldrich). Protein production was scaled up to 2-liter baffled
flasks using the same medium and conditions, incubated at
37 °C until A600 reached 0.5 then the temperature was reduced
to 25 °C (TgSPT1 158, 177, and 180) and incubation con-
tinued for a further 24 h or 15 °C (TgSPT1 143) and 48 h.
Following harvesting of the cells by centrifugation and freeze-
thawing at80 °C, the pelletswere suspended in lysis buffer (50
mM Tris, pH 7.5, 500 mM NaCl, 20 mM imidazole, 0.2% Tween
20 (v/v), 10 g/ml DNase, 10 g/ml RNase (all Sigma-Al-
drich), and EDTA-free protease inhibitors (Roche)) before lysis
by sonication and isolation of the soluble fraction following
centrifugation. HIS-SUMO-tagged TgSPT1 fusions were then
isolated using a His trap FF 5-ml column (GE Healthcare Life
Sciences) equilibrated with 50 mM Tris, pH 7.6, 500 mM NaCl,
20 mM imidazole, 25 M PLP ,and 5% glycerol (v/v) (all Sigma-
Aldrich), and FPLC (Akta). Bound proteinwas then eluted in 50
mM Tris, pH 7.6, 500 mM NaCl, 1 M imidazole, 25 M PLP, and
5% glycerol (v/v) before dialysis into 10 mM Tris, pH 7.6, 150
mM NaCl, 25 M PLP, and 5% glycerol (v/v) using a Slide-A-
Lyzer cassette (Thermo Scientific). To cleave the purification
tag, the dialysis step was performed in the presence of the
Human RhinoVirus 3C Protease (HRV 3C; Qiagen). Following
concentration using a spin concentrator (Agilent Technolo-
gies), samples were injected onto on a 1-ml MonoQ 5/50 GL
anion exchange column (GE Healthcare) pre-equilibrated with
wash buffer (10 mM Tris, pH 8, 100 mMNaCl) using FPLC. The
flow-through, containing cleaved and purified protein, was col-
lected, concentrated, and dialyzed in appropriate buffers, and
quantified using a Nanodrop 2000.
TgSPT enzymatic assay
Initially, TgSPT1 activity was assessed using a methodology
based on a published radiochemical assay (21). In a 500-l reac-
Figure 8. A, schematic illustrating the gene arrangement in the region surrounding the encoded C. muris serine palmitoyltransferase, compared with the
syntenic regions of C. parvum and C. hominis chromosome 6. B, phylogenetic tree produced from a genetic distancematrix showing the relationship between
the eukaryotic catalytic subunit of serine palmitoyltransferase (LCB2) and the prokaryotic and apicomplexan orthologues (SPT). TheOpistokonta (animals and
fungi) are colored blue; the Excavata (subgroup of unicellular eukaryotes) are yellow; Amoebozoa (amoeboid protozoa) are gray; Archaeplastida (plants and
algae, containing cyanobacterium-derived plastid) are green; Rodophyta (a subgroup of the Archaeplastida, red algae) are red; Chromalveolata (unicellular
eukaryotes containing red algal derived plastid) are turquoise; and Sphingomonadales (alphaproteobacteria with the ability to synthesize sphingolipids) are
pink. The bootstrap values of the major clades are shown where they are greater than 60 at common nodes for the three methodologies employed: F-MDist,
RAxML, andPhyML. The non-catalytic subunit of the human serine palmitoyltransferase (HsLCB1)was utilized as the outgroup. Sequences used in the analyses
were equivalent to those aligned to TgSPT1 amino acids 228–411. Sequence information: LCB1, serine palmitoyltransferase subunit 1; LCB2, palmitoyltrans-
ferase subunit 2; SPT, serine palmitoyltransferase. NBCI accession numbers: HsLCB1:Homo sapiens, EAW62806; HsLCB2: H. sapiens, NP_004854; MmLCB2:Mus
muscalis, NP_035609; DmLCB2: Drosophila melanogaster, BAA83721; CeLCB2: Caenorhabditis elegans, Q20375; DrLCB2, Danio rerio, NP_001108213; OsLCB2:
Oryza sativa, BAD88168.1; AtLCB2: Arabidopsis thaliana, NP_001031932.1; DdLCB2: Dictyostelium discodium, XP_635115. Joint Genome Institute accession
numbers: NvLCB2: Nematostella vectensis, 241814; MbLCB2: Monosiga brevicollis, 34401; PtLCB2: Populus trichocarpa, 834365; OtLCB2: Ostreococcus tauri,
16411; TpLCB2: T. pseudonana, 255691; PrLCB2: P. ramorum, 71166; NgLCB2: Naegleria gruberi, 82916; SpSPT: S. paucimobilis, Q93UV0_PSEPA; SmSPT: S. mul-
tivorum, A7BFV6_9SPHI; SsSPT: Sphingobacterium spiritivorum, A7BFV7_9SPHI; BsSPT: Bacteriovorax stolpii, A7BFV8_9DELT. Universal Protein Resource acces-
sion numbers: ScLCB2: S. cerevisiae, P40970; CnLCB2: Cryptococcus neoformans, J9VYF7; SpLCB2: Schizosaccharomyces pombe, Q09925; AnLCB2: Aspergillus
nidulans, Q5BEC8; RoLCB2:Rhizopusoryzae, I1BXF5.CyanidioschyzonmerolaeGenomeProject accessionnumber: CmLCB2:Cyanidioschyzonmerolae, CMJ240C.
ToxoDB accession numbers: TgSPT1: T. gondii, TGME49_090980; TgSPT2, TGME49_090970. GeneDB accession numbers: PfSPT: P. falciparum, PF14_0155;
PvSPT, P. vivax; CmSPT: C. muris, B6ACS8_CRYMR; TbLCB2: Trypanosoma brucei, Tb927.10.4050; LmLCB2: Leishmania major, LmjF35.0320. Sanger Institute
accession number: EtSPT: E. tenella, dev_EIMER_contig_00020813.
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tion volume (50MHEPES, pH7.6, 150mMKCl, 0.2mMEDTA,
5% glycerol, 25 M PLP), 20 M of the purified protein was
reacted with 20 mM L-[14C]serine (GE Healthcare) and 1.6 mM
palmitoyl CoA (Sigma-Aldrich) for 75 min at 37 °C. The
organic phase was isolated following the addition of 1 ml of
CHCl3:CH3OH (2:1 v/v) and analyzed by high-performance
thin layer chromatography (Merck) in a CHCl3:CH3OH:
NH4OH, 40:10:1, solvent system. Images were captured using a
AR-2000 Radio-TLC and Imaging Scanner (Bioscan). Subse-
quently, mass spectrometry was utilized to definitively identify
the reaction products under the same conditions as above, but
using cold serine and 5-fold greater volumes. Following purifi-
cation as above, reaction products were analyzed, and accurate
masses were obtained, using a Thermo-Finnigan LTQ FTmass
spectrometer.
Subcellular localization of TgSPT1
Primers were designed to amplify the TgSPT1 coding
sequence: TgSPT5EcoRV CGCGATATCATGGCTTCG-
GGTGCAACGTACTTC and TgSPT3NsiI CGCATGCA-
TTCGGAGCATGTCAGTGGGTGG (with restriction sites in
bold type). The resultant PCR product was cloned into
pTUB8MycGFPPfMyoAtailTy-HX (kind gift from Dominique
Soldati-Favre) (47) to create pG1-TgSPT1-TY. Transfections
were carried out using a 4D Nucleofector (Lonza), protocol FI
158 and 20-l reaction volumes in 16 reaction strips. Briefly,
Toxoplasma were maintained in human foreskin fibroblasts
(HFFs, ATCC). Parasites freshly lysed from one T75 flask of
HFF cells were homogenized by passage through a 25-gauge
needle and isolated by centrifugation at 1500 g for 10 min at
4 °C. The pellet was resuspended in the P3 buffer with added
supplement (Lonza), and Toxoplasma concentration was
adjusted to 107 ml1. 20 l of this parasite suspension was
added to a dried pellet of ethanol-precipitated	10 g of P30-
GFP-HDEL (kind gift from Kristin Hager, University of Notre
Dame) (48), and/or pG1-TgSPT1-TY plasmid was transferred
to the transfection strips and electroporated. Subsequently, 100
l of medium was added, and 10 l or 20 l were added to
24-well plates containing confluent HFF cells grown on glass
coverslips. The plates were incubated at 37 °C, 5.0%CO2 for the
appropriate time period.
The cells were fixed in 4% paraformaldehyde in PBS (pH 7.4)
for 15min and then permeablized with 0.4% (v/v) Triton X-100
in PBS for 10 min, before incubation in blocking buffer (PBS
supplemented with 1% (w/v) BSA; Sigma-Aldrich), 0.1% fish
skin gelatin (Sigma-Aldrich), and 0.1% (v/v) Triton X-100) for
15 min at room temperature. Samples were incubated with a
mouse monoclonal anti-TY antibody (1:200; kind gift from
Keith Gull, University of Oxford, Oxford, UK) or the primary
anti-TgSPT1 158 rat polyclonal (Cambridge Research Bio-
chemicals, 1:200), and an anti-GFP rabbit polyclonal antibody
(Clontech, 1:200) in blocking buffer overnight at 4 °C.After PBS
washing, samples were incubated with Alexa Fluor 594 anti-
mouse or anti-rat and Alexa Fluor 488 anti-rabbit secondary
antibodies (ThermoFisher) at 1:500 in blocking buffer for 1 h at
room temperature. The samples were incubated with DAPI
(Sigma-Aldrich) in PBS for 10 min, mounted using Vectashield
H-1000 (Vector labs), and sealed with nail polish before
imaging.
All images were obtained using laser scanning confocal
microscope Zeiss LSM 880 with AiryScan equipped with exci-
tation laser 405, Argon 458, 488, 514, He-Ne 543, 594, and 633
and AiryScan filter set combinations BP 420–480  BP 495–
550, BP 420–480  BP 495–620, BP 420–480  LP 605, BP
465–505 LP 525, BP 495–550 LP 570, and BP 570–620
LP 645. For each image, the dynamic range was checked to
avoid saturation, except with the DAPI stain where host cells
masked the detection of parasite nuclei at low gain/laser power
values. AiryScan images were automatically processed using
default values. Zeiss CZI images were exported to TIFF file
format using Zen (Blue Edition version 2.3, Carl Zeiss Micros-
copyGmbH, 2011) and analyzed using ImageJ Fiji package (49).
Co-localization was assessed using the ScatterJn plugin and
scatter plots (36, 37). The scatterplots show two-dimensional
histograms of two channels at the same spatial region. Data
points are generated as n(x,y), where n is the number of pixels in
each channel, and x,y are discrete values 0–255, and these data
points are displayed as a scatterplot of 256  256 matrix in
which the element (x,y) contains the number of data pointswith
coordinates (x,y). Thenumber of pixels is represented by a color
scale. A linear correlation demonstrates a strong spatial corre-
lation between the channels, and the slope indicates the relative
intensities. Negative controls were checked between DAPI and
the Golgi marker, pTub-GRASP-RFP (50), and no positive cor-
relation was found.
Homologymodeling
The TgSPT1 homology model was constructed using the
158 SPT sequence with the HHPred server (http://toolkit.
tuebingen.mg.de/hhpred (62))3 (51), which identified the crys-
tal structure of SPT from S. multivorum (52) as the closest
orthologue (Protein Data Bank code 3A2B) and aligned the
sequences based on sequence identity and the predicted sec-
ondary structure of TgSPT1 and the actual secondary structure
of 3A2B. The biologically relevant homodimer was used as a
template to produce five preliminarymodels withMODELLER
(53). The model with the lowest molpdf score was taken for-
ward to the next step, in which PLP was added based on the
known bacterial SPT structure. After another minimizing step,
the two loops of residues 472–494 that are absent in the bacte-
rial structure, were modeled usingMODELLER (54). The opti-
mal conformation was based on the lowest molpdf and DOPE
scores, as well as manual inspection using interactive computer
graphics.
Small angle X-ray scattering
SAXS data were collected using the 158 SPT construct on
Beamline B21 at the Diamond Light Source in size exclusion
chromatography HPLCmode (55). Prior to data collection, the
sample was concentrated to 	5 mg/ml. The elution peak was
exposed for 5 min. The images collected after the 4-min mark
showed signs of radiation damage by analysis of radius of gyra-
tion and were discarded. The raw images were processed, and
the background as subtracted in DAWN (56) at the beamline.
Low q values outside the linear part of the Guinier plot were
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removed in ScÅtter along with q 0.2519 andDmax calculated
to 133 Å. Further data processing was performed using ATSAS
(57). PRIMUS calculated Dmax to 138 Å and the Porod volume
to 150387 Å3, equivalent to 94 kDa using the rule of thumb of
dividing the Porod volume by 1.6 Å3/Da, a good fit of a dimer of
the TgSPT1 D158 construct at 46 kDa per monomer. Fifteen
2-fold dimer envelope models were created in DAMMIF using
the ATSAS server, a consensus envelope was created by
DAMAVER, and that envelope was used as a starting point for
DAMMIN (58). The DAMMIN envelope was superposed with
the homology model in SUPCOMB, and the result was ren-
dered in PyMol 1.7. CRYSOL (31) was used to calculate the
theoretical X-ray scattering data from the homology model.
Phylogenetic analyses
The selected predicted protein sequences were aligned using
ClustalW, edited to remove non-aligned regions, and then
realigned in ClustalWwith the output selected as a PHYLIP file
(supplemental Fig. S3). This alignment was then subjected to
three different phylogenetic analyses: F-MDist (39), RAxML
(40), and PhyML (41). Bootstrap valueswere calculated for each
analysis and used to establish the strength of the common
clades in a consensus tree generated from the F-MDist data
using DRAWGRAM in PHYLIP (39).
Author contributions—J. G. M., J. K. T., and A. Q. I. A. conducted
most of the experiments and analyzed the results. L. E. B. managed
the construct assembly and analyses at Oxford Protein Purification
Facility. R. H. D. optimized the protein expression. M. K. G. per-
formed the SAXS experimental and analyses. J. A. M. conducted the
mass spectrometry. S. P. cloned the cDNA. H. S.-E. constructed the
conditional yeast mutant. R. T. S., E. P., and P. W. D. designed and
managed the experimental. P. W. D. conceived the idea for the pro-
ject and wrote the paper with E. P. and J. G. M.
Acknowledgments—We thank the Department of Chemistry Mass
Spectrometry Service for analytical support. Also, thanks to Martin
Walsh from the Diamond Light Source; Christopher Barnes, Ian
Edwards, Tim Hawkins, Joanne Robson, Catherine Bruce, and Emily
Cardew from the Department of Biosciences; and Robek Pal from the
Department of Chemistry for technical input, support, and many
helpful discussions. We gratefully acknowledge the provision of beam
time and excellent support by the BL21 staff at the Diamond Light
Source. Materials were kindly provided by Prof. Dominique Soldati-
Favre (Geneva), Dr. KristinHagar (NotreDame), and Prof. KeithGull
(Oxford). This work was also supported by Grant-in-Aid fromOxford
Protein Purification Facility.
References
1. Chowdhury, M. N. (1986) Toxoplasmosis: a review. J. Med. 17, 373–396
2. Dubey, J. P. (1977) Toxoplasma, Hammondia, Besnotia, Sarcocystis, and
other cyst-forming coccidia of man and animals. In: Parasitic Protozoa
(Kreier, J. P., ed) pp. 101–237, Academic Press, New York
3. Coppens, I. (2013) Targeting lipid biosynthesis and salvage in apicompl-
exan parasites for improved chemotherapies. Nat. Rev. Microbiol. 11,
823–835
4. Coppens, I. (2014) Exploitation of auxotrophies and metabolic defects in
Toxoplasma as therapeutic approaches. Int. J. Parasitol. 44, 109–120
5. Azzouz, N., Rauscher, B., Gerold, P., Cesbron-Delauw, M. F., Dubremetz,
J. F., and Schwarz, R. T. (2002) Evidence for de novo sphingolipid biosyn-
thesis in Toxoplasma gondii. Int. J. Parasitol. 32, 677–684
6. Pratt, S., Wansadhipathi-Kannangara, N. K., Bruce, C. R., Mina, J. G.,
Shams-Eldin, H., Casas, J., Hanada, K., Schwarz, R. T., Sonda, S., and
Denny, P. W. (2013) Sphingolipid synthesis and scavenging in the intra-
cellular apicomplexan parasite, Toxoplasma gondii. Mol. Biochem. Para-
sitol. 187, 43–51
7. Romano, J. D., Sonda, S., Bergbower, E., Smith, M. E., and Coppens, I.
(2013) Toxoplasma gondii salvages sphingolipids from the host Golgi
through the rerouting of selected Rab vesicles to the parasitophorous vac-
uole.Mol. Biol. Cell 24, 1974–1995
8. Prieschl, E. E., and Baumruker, T. (2000) Sphingolipids: second messen-
gers, mediators and raft constituents in signaling. Immunol. Today 21,
555–560
9. Pszenny, V., Ehrenman, K., Romano, J. D., Kennard, A., Schultz, A., Roos,
D. S., Grigg, M. E., Carruthers, V. B., and Coppens, I. (2016) A lipolytic
lecithin:cholesterol acyltransferase secreted by Toxoplasma facilitates
parasite replication and egress. J. Biol. Chem. 291, 3725–3746
10. Young, S. A., Mina, J. G., Denny, P. W., and Smith, T. K. (2012) Sphingo-
lipid and ceramide homeostasis: potential therapeutic targets. Biochem.
Res. Int. 2012, 248135
11. Simons, K., and Ikonen, E. (1997) Functional rafts in cell membranes.
Nature 387, 569–572
12. Lowther, J., Naismith, J. H., Dunn, T. M., and Campopiano, D. J. (2012)
Structural, mechanistic and regulatory studies of serine palmitoyltrans-
ferase. Biochem. Soc. Trans. 40, 547–554
13. Hanada, K. (2003) Serine palmitoyltransferase, a key enzyme of sphingo-
lipid metabolism. Biochim. Biophys. Acta 1632, 16–30
14. Han, G., Gable, K., Yan, L., Natarajan, M., Krishnamurthy, J., Gupta, S. D.,
Borovitskaya, A., Harmon, J. M., and Dunn, T. M. (2004) The topology of
the Lcb1p subunit of yeast serine palmitoyltransferase. J. Biol. Chem. 279,
53707–53716
15. Nagiec, M. M., Baltisberger, J. A., Wells, G. B., Lester, R. L., and Dickson,
R. C. (1994) The LCB2 gene of Saccharomyces and the related LCB1 gene
encode subunits of serine palmitoyltransferase, the initial enzyme in sph-
ingolipid synthesis. Proc. Natl. Acad. Sci. U.S.A. 91, 7899–7902
16. Zanolari, B., Friant, S., Funato, K., Sütterlin, C., Stevenson, B. J., and Riez-
man, H. (2000) Sphingoid base synthesis requirement for endocytosis in
Saccharomyces cerevisiae. EMBO J. 19, 2824–2833
17. Perry, D. K. (2002) Serine palmitoyltransferase: role in apoptotic de novo
ceramide synthesis and other stress responses. Biochim. Biophys. Acta
1585, 146–152
18. Funato, K., Vallée, B., and Riezman, H. (2002) Biosynthesis and trafficking
of sphingolipids in the yeast Saccharomyces cerevisiae. Biochemistry 41,
15105–15114
19. Ikushiro, H., Hayashi, H., and Kagamiyama, H. (2003) Bacterial serine
palmitoyltransferase: a water-soluble homodimeric prototype of the eu-
karyotic enzyme. Biochim. Biophys. Acta 1647, 116–120
20. Ikushiro, H., Hayashi, H., and Kagamiyama, H. (2001) A water-soluble
homodimeric serine palmitoyltransferase from Sphingomonas paucimo-
bilis EY2395T strain: purification, characterization, cloning, and overpro-
duction. J. Biol. Chem. 276, 18249–18256
21. Yard, B. A., Carter, L. G., Johnson, K. A., Overton, I. M., Dorward,M., Liu,
H., McMahon, S. A., Oke, M., Puech, D., Barton, G. J., Naismith, J. H., and
Campopiano, D. J. (2007) The structure of serine palmitoyltransferase;
gateway to sphingolipid biosynthesis. J. Mol. Biol. 370, 870–886
22. Gerold, P., and Schwarz, R. T. (2001) Biosynthesis of glycosphingolipids
de-novo by the human malaria parasite Plasmodium falciparum. Mol.
Biochem. Parasitol. 112, 29–37
23. Lauer, S. A., Ghori, N., and Haldar, K. (1995) Sphingolipid synthesis as a
target for chemotherapy against malaria parasites. Proc. Natl. Acad. Sci.
U.S.A. 92, 9181–9185
24. Haldar, K.,Mohandas, N., Samuel, B. U., Harrison, T., Hiller, N. L., Akom-
pong, T., and Cheresh, P. (2002) Protein and lipid trafficking induced in
erythrocytes infected by malaria parasites. Cell Microbiol. 4, 383–395
25. Shams-Eldin, H., Azzouz, N., Kedees, M. H., Orlean, P., Kinoshita, T., and
Schwarz, R. T. (2002) TheGPI1 homologue from Plasmodium falciparum
complements a Saccharomyces cerevisiae GPI1 anchoring mutant. Mol.
Biochem. Parasitol. 120, 73–81
The apicomplexan serine palmitoyltransferase
12218 J. Biol. Chem. (2017) 292(29) 12208–12219
 by guest on D
ecem
ber 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
26. Denny, P. W., and Smith, D. F. (2004) Rafts and sphingolipid biosynthesis
in the kinetoplastid parasitic protozoa.Mol. Microbiol. 53, 725–733
27. Denny, P. W., Goulding, D., Ferguson, M. A., and Smith, D. F. (2004)
Sphingolipid-free Leishmania are defective in membrane trafficking, dif-
ferentiation and infectivity.Mol. Microbiol. 52, 313–327
28. Ikushiro, H., Islam, M. M., Tojo, H., and Hayashi, H. (2007) Molecular
characterization of membrane-associated soluble serine palmitoyltrans-
ferases from Sphingobacterium multivorum and Bdellovibrio stolpii. J.
Bacteriol. 189, 5749–5761
29. Berrow, N. S., Alderton, D., Sainsbury, S., Nettleship, J., Assenberg, R.,
Rahman, N., Stuart, D. I., andOwens, R. J. (2007) A versatile ligation-inde-
pendent cloning method suitable for high-throughput expression screen-
ing applications. Nucleic Acids Res. 35, e45
30. Bird, L. E. (2011)High throughput construction and small scale expression
screening of multi-tag vectors in Escherichia coli.Methods 55, 29–37
31. Svergun, D., Barberato, C., and Koch,M.H. (1995) CRYSOL: a program to
evaluate X-ray solution scattering of biological macromolecules from
atomic coordinates. J. Appl. Crystallogr. 28, 768–773
32. Zuegge, J., Ralph, S., Schmuker, M., McFadden, G. I., and Schneider, G.
(2001) Deciphering apicoplast targeting signals: feature extraction from
nuclear-encoded precursors of Plasmodium falciparum apicoplast pro-
teins. Gene 280, 19–26
33. van Dooren, G. G., and Striepen, B. (2013) The algal past and parasite
present of the apicoplast. Annu. Rev. Microbiol. 67, 271–289
34. Agrawal, S., van Dooren, G. G., Beatty, W. L., and Striepen, B. (2009)
Genetic evidence that an endosymbiont-derived endoplasmic reticulum-
associated protein degradation (ERAD) system functions in import of api-
coplast proteins. J. Biol. Chem. 284, 33683–33691
35. Ramakrishnan, S., Docampo,M.D.,Macrae, J. I., Pujol, F.M., Brooks, C. F.,
vanDooren, G. G., Hiltunen, J. K., Kastaniotis, A. J., McConville,M. J., and
Striepen, B. (2012) Apicoplast and endoplasmic reticulum cooperate in
fatty acid biosynthesis in apicomplexan parasite Toxoplasma gondii.
J. Biol. Chem. 287, 4957–4971
36. Zeitvogel, F., and Obst, M. (2016) ScatterJn: An ImageJ plugin for scatter-
plot-matrix analysis and classification of spatially resolved analytical mi-
croscopy data. J. Open Res. Software 4, e5
37. Zeitvogel, F., Schmid, G., Hao, L., Ingino, P., and Obst, M. (2016) ScatterJ:
an ImageJ plugin for the evaluation of analytical microscopy datasets. J.
Microsc. 261, 148–156
38. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan,
P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R.,
Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and
Clustal X version 2.0. Bioinformatics 23, 2947–2948
39. Felsenstein, J. (1989) Mathematics vs. evolution: mathematical evolution-
ary theory. Science 246, 941–942
40. Stamatakis, A. (2014) RAxML version 8: a tool for phylogenetic analysis
and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313
41. Guindon, S., andGascuel, O. (2003) A simple, fast, and accurate algorithm
to estimate large phylogenies by maximum likelihood. Syst. Biol. 52,
696–704
42. Arisue, N., and Hashimoto, T. (2015) Phylogeny and evolution of apico-
plasts and apicomplexan parasites. Parasitol. Int. 64, 254–259
43. Huitema, K., van den Dikkenberg, J., Brouwers, J. F., and Holthuis, J. C.
(2004) Identification of a family of animal sphingomyelin synthases.
EMBO J. 23, 33–44
44. Di Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A.,
Chang, J. M., Taly, J. F., and Notredame, C. (2011) T-Coffee: a web server
for the multiple sequence alignment of protein and RNA sequences using
structural information and homology extension. Nucleic Acids Res. 39,
W13–W17
45. Denny, P., Preiser, P., Williamson, D., andWilson, I. (1998) Evidence for a
single origin of the 35 kb plastid DNA in apicomplexans. Protist 149,
51–59
46. Denny, P. W., Shams-Eldin, H., Price, H. P., Smith, D. F., and Schwarz,
R. T. (2006) The protozoan inositol phosphorylceramide synthase: a novel
drug target that defines a new class of sphingolipid synthase. J. Biol. Chem.
281, 28200–28209
47. Herm-Götz, A., Weiss, S., Stratmann, R., Fujita-Becker, S., Ruff, C., Mey-
hfer, E., Soldati, T., Manstein, D. J., Geeves, M. A., and Soldati, D. (2002)
Toxoplasma gondii myosin A and its light chain: a fast, single-headed,
plus-end-directed motor. EMBO J. 21, 2149–2158
48. Hager, K.M., Striepen, B., Tilney, L. G., and Roos, D. S. (1999) The nuclear
envelope serves as an intermediary between the ER and Golgi complex in
the intracellular parasite Toxoplasma gondii. J. Cell Sci. 112, 2631–2638
49. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to
ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675
50. Pfluger, S. L., Goodson, H. V., Moran, J. M., Ruggiero, C. J., Ye, X.,
Emmons, K.M., and Hager, K.M. (2005) Receptor for retrograde trans-
port in the apicomplexan parasite Toxoplasma gondii. Eukaryot. Cell 4,
432–442
51. Söding, J., Biegert, A., and Lupas, A. N. (2005) The HHpred interactive
server for protein homology detection and structure prediction. Nucleic
Acids Res. 33,W244–W248
52. Ikushiro, H., Islam,M.M., Okamoto, A., Hoseki, J., Murakawa, T., Fujii, S.,
Miyahara, I., andHayashi, H. (2009) Structural insights into the enzymatic
mechanism of serine palmitoyltransferase from Sphingobacterium multi-
vorum. J. Biochem. 146, 549–562
53. Eswar, N.,Webb, B., Marti-Renom,M. A., Madhusudhan,M. S., Eramian,
D., Shen, M. Y., Pieper, U., and Sali, A. (2006) Comparative protein struc-
ture modeling using Modeller. Curr. Protoc. Bioinformatics, Chapter 5,
Unit 5.6
54. Fiser, A., and Sali, A. (2003) ModLoop: automated modeling of loops in
protein structures. Bioinformatics 19, 2500–2501
55. De Maria Antolinos, A., Pernot, P., Brennich, M. E., Kieffer, J., Bowler,
M. W., Delageniere, S., Ohlsson, S., Malbet Monaco, S., Ashton, A.,
Franke, D., Svergun, D., McSweeney, S., Gordon, E., and Round, A. (2015)
ISPyB for BioSAXS, the gateway to user autonomy in solution scattering
experiments. Acta Crystallogr. D Biol. Crystallogr. 71, 76–85
56. Basham, M., Filik, J., Wharmby, M. T., Chang, P. C., El Kassaby, B., Ger-
ring,M., Aishima, J., Levik, K., Pulford, B. C., Sikharulidze, I., Sneddon, D.,
Webber, M., Dhesi, S. S., Maccherozzi, F., Svensson, O., et al. (2015) Data
analysis WorkbeNch (DAWN). J. Synchrotron Radiat. 22, 853–858
57. Petoukhov, M. V., Franke, D., Shkumatov, A. V., Tria, G., Kikhney, A. G.,
Gajda, M., Gorba, C., Mertens, H. D., Konarev, P. V., and Svergun, D. I.
(2012) New developments in the program package for small-angle scat-
tering data analysis. J. Appl. Crystallogr. 45, 342–350
58. Tuukkanen, A. T., Kleywegt, G. J., and Svergun, D. I. (2016) Resolution of
ab initio shapes determined from small-angle scattering. IUCrJ 3,
440–447
59. Gouet, P., Robert, X., andCourcelle, E. (2003) ESPript/ENDscript: extract-
ing and rendering sequence and 3D information from atomic structures of
proteins. Nucleic Acids Res. 31, 3320–3323
60. Gajria, B., Bahl, A., Brestelli, J., Dommer, J., Fischer, S., Gao, X., Heiges,M.,
Iodice, J., Kissinger, J. C., Mackey, A. J., Pinney, D. F., Roos, D. S., Stoeck-
ert, C. J., Jr., Wang, H., and Brunk, B. P. (2008) ToxoDB: an integrated
toxoplasma gondii database resource. Nucleic Acids Res. 36, D553–D556
61. Aurrecoechea, C., Brestelli, J., Brunk, B. P., Dommer, J., Fischer, S.,
Gajria, B., Gao, X., Gingle, A., Grant, G., Harb, O. S., Heiges, M., In-
namorato, F., Iodice, J., Kissinger, J. C., Kraemer E., et al. (2009) Plas-
moDB: a functional genomic database for malaria parasites. Nucleic
Acids Res. 37, D539–D543
62. Alva, V., Nam, S. Z., So¨ding, J., and Lupas, A. N. (2016) TheMPI bioinfor-
matics Toolkit as an integrative platform for advanced protein sequence
and structure analysis. Nucleic Acids Res. 44,W410–W415
The apicomplexan serine palmitoyltransferase
J. Biol. Chem. (2017) 292(29) 12208–12219 12219
 by guest on D
ecem
ber 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Schwarz, Ehmke Pohl and Paul W. Denny
Morten K. Grøftehauge, Jackie A. Mosely, Steven Pratt, Hosam Shams-Eldin, Ralph T. 
John G. Mina, Julie K. Thye, Amjed Q. I. Alqaisi, Louise E. Bird, Robert H. Dods,
sphingolipid biosynthesis in a phylum of eukaryotic protozoan parasites
Functional and phylogenetic evidence of a bacterial origin for the first enzyme in
doi: 10.1074/jbc.M117.792374 originally published online June 2, 2017
2017, 292:12208-12219.J. Biol. Chem. 
  
 10.1074/jbc.M117.792374Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2017/06/02/M117.792374.DC1
  
 http://www.jbc.org/content/292/29/12208.full.html#ref-list-1
This article cites 60 references, 17 of which can be accessed free at
 by guest on D
ecem
ber 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
